In a PNAS paper just out Yu and coworkers showed that the small molecule NEDD8-activating enzyme (NAE) inhibitor MLN4924 (pevonedistat, Focus Cat# 10-1311) reduces ischemic brain injury in a mouse model. The study found that neddylation increases in the acute phase following ischemic stroke, and treatment with MLN4924 protects against the resulting inflammation and blood–brain barrier (BBB) disruption.
Website Created by Advanta Advertising LLC.
